Schubert & Co’s Novartis NVS Stock Holding History

Schubert & Co’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-112	Closed	-$10.3K	–	1024
2023 Q1	$10.3K	Hold	112	–	–	0.01%	217
2022 Q4	$10.2K	Sell	112 -25	-18%	-$2.11K	0.01%	220
2022 Q3	$10K	Hold	137	–	–	0.01%	199
2022 Q2	$12K	Buy	137 +25	+22%	+$2.19K	0.01%	161
2022 Q1	$10K	Buy	+112	New	+$9.7K	0.01%	116

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Schubert & Co's NVS Position: Q2 2023 in Review

Schubert & Co sold out of Novartis (NVS) in Q2 2023, closing a stake of 112 shares — an estimated $10.3K sold.

Schubert & Co first reported a position in NVS in Q1 2022 and held it in 5 quarters. The position peaked at $12K in Q2 2022. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.

Schubert & Co reported no remaining Novartis position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 112 Novartis shares in Q2 2023, an estimated $10.3K.
Schubert & Co first reported a position in Novartis in Q1 2022 and held it in 5 quarters.
Schubert & Co's Novartis position peaked at $12K in Q2 2022.
1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.